About VivoSense
VivoSense is a Healthcare company based in San Diego (United States) founded in 2010 by Dudley Tabakin and Lance Myers. Wearable sensor research analysis platform. VivoSense has raised $27.46 million across 6 funding rounds from investors including Debiopharm and Perceptive Advisors. Its chief executive, as recorded, is Dudley Tabakin. VivoSense offers products and services including Wearable Sensor Services, Design and Configure, Data Collection and Cleaning, and Insight Delivery. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Clinical Trials. Its competitors include Curebase, L7 Informatics and Clinical Research IO; 3 of its 3 listed competitors have raised funding.
Company details
VivoSense was established in 2010 in San Diego, United States, within the health technology sector focused on clinical research. Wearable sensor solutions, data analysis services, and algorithm development are provided by Vivonoetics for trials involving data collection. The VivoSense platform supports analysis across disease states such as sleep disordered breathing, congestive heart failure, and cystic fibrosis. Over 500 pharmaceutical, research, and academic institutions have utilized these services globally.
- Headquarters San Diego, United States
- Founders Dudley Tabakin, Lance Myers
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website vivosense.com
- Social LinkedIn X Facebook
- Total Equity Funding$27.46M (USD)
in 6 rounds
- Latest Funding Round$25M (USD), Series A
Mar 2022
- InvestorsDebiopharm
& 1 more
Products & Services of VivoSense
VivoSense offers a comprehensive portfolio of products and services, including Wearable Sensor Services, Design and Configure, Data Collection and Cleaning, and Insight Delivery.
End-to-end implementation of wearable tech for clinical trials.
Tools for designing wearable sensor setups in research.
Services to generate and clean sensor data for trials.
Interpreting sensor data to deliver actionable insights.
Funding Insights of VivoSense
VivoSense has successfully raised a total of $27.46M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $25 million completed in March 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $27.46M
- Total Rounds 6
- Last Round Series A — $25M
- First Round $120,000
(Nov 2017)
- Investors Count 2
All 6 funding rounds of VivoSense with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2022 | $25M | Series A | – | Debiopharm, Perceptive Advisors | – |
| Aug 2020 | $150,000 | Series A | – | – | – |
| May 2019 | $2M | Series A | – | – | – |
| Jan 2019 | $105,000 | Series A | – | – | – |
| Apr 2018 | $90,000 | Seed | – | – | – |
| Nov 2017 | $120,000 | Seed | – | – | – |
2 investors in total: 2 institutional.
Investors in VivoSense
VivoSense has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Debiopharm and Perceptive Advisors.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Health-tech companies are targeted for venture capital investments. | 1999 | perceptivelife.com | New York, United States | |
Biopharmaceutical company focused on oncology, infectious diseases, and orphan drugs | 1979 | debiopharm.com | Lausanne, Switzerland |
Investor details for VivoSense
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of VivoSense
12 people are tracked at VivoSense (7 in leadership, 5 in team).
| Name | Role | Group |
|---|---|---|
Dudley Tabakin | Co-Founder & CEO | Leadership |
Lance Myers | Co-Founder | Leadership |
Chris Garabedian | Managing Director | Leadership |
Kate Lyden | Chief Science Officer | Leadership |
Doug McAllister | Chief Technology Officer | Leadership |
Peter Foster | Chief Business Advisor | Leadership |
Ralf Hempfling | Chief Algorithm Officer | Leadership |
Tarek Hamid | Algorithms Engineer | Team |
Marc Mintz | Senior Executive Business Advisor | Team |
Tony Jones | Software Development Engineer | Team |
Tracy Swibas | Project Manager | Team |
Jen Blankenship | Senior Research Scientist | Team |
Complete people profiles for VivoSense
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of VivoSense
3 dated milestones of VivoSense across 12 years, from founding to its latest funding, stage changes and deals.
- Founded VivoSense is founded.
- Funding First funding round of $120K.
- Funding Latest funding round, Series A, of $25.0M.
Competitors of VivoSense
VivoSense has 3 listed competitors in our database, 3 of them funded. They include Curebase, L7 Informatics and Clinical Research IO.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| curebase.com | 2017 | San Francisco, United States | $59.01M | 94 | Patient enrollment platform for decentralized clinical research is provided. | |
| l7informatics.com | 2012 | Austin, United States | $54.97M | 126 | Clinical trial workflow management software is provided for laboratories. | |
| clinicalresearch.io | 2015 | Boston, United States | $16.7M | 16 | Clinical trial management software is provided for research sites. |
Detailed competitors of VivoSense
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of VivoSense
The website of VivoSense (vivosense.com) receives about 2.6K visits a month.
- Monthly visits2.6K
▼ 20.1% vs previous month
Websites whose visitors overlap most with VivoSense. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
limbic-cenc.org | limbic-cenc.org | 100% | #4,940,703 | – |
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as VivoSense (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Vivosense
Complete news archive for VivoSense
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about VivoSense
VivoSense was founded in 2010 and raised its 1st funding round 7 years after it was founded.
VivoSense is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Dudley Tabakin is the CEO of VivoSense, as recorded in our data. They have also founded this company.
VivoSense is a funded company, having raised a total of $27.46M across 6 funding rounds to date. The company's 1st funding round was a Seed of $120K, raised on Nov 2017.
VivoSense was established in 2010 in San Diego, United States, within the health technology sector focused on clinical research. Wearable sensor solutions, data analysis services, and algorithm development are provided by Vivonoetics for trials involving data collection. The VivoSense platform supports analysis across disease states such as sleep disordered breathing, congestive heart failure, and cystic fibrosis. Over 500 pharmaceutical, research, and academic institutions have utilized these services globally.
VivoSense's top competitors include L7 Informatics, Curebase and Clinical Research IO.
VivoSense offers Wearable Sensor Services, Design and Configure, Data Collection and Cleaning, and Insight Delivery.
VivoSense has 2 investors. Key investors include Debiopharm, and Perceptive Advisors.